The Synthetic Antimicrobial Peptide Pexiganan and Its Nanoparticles (PNPs) Exhibit the Anti-Helicobacter pylori Activity in Vitro and in Vivo

Resistance of Helicobacter pylori to tetracycline, amoxicillin, clarithromycin and metronidazole in Israeli children and adults

(2014) Avi Peretz et al.   JOURNAL OF ANTIBIOTICS

How Long Will It Take to Reduce Gastric Cancer Incidence by Eradicating Helicobacter Pylori Infection?

(2013) J. F. Osborn et al.   Cancer Prevention Research

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial

(2012) Jyh-Ming Liou et al.   LANCET

Antimicrobial Peptides: Primeval Molecules or Future Drugs?

(2010) Brian M. Peters et al.   PLoS Pathogens

Development of pH-responsive chitosan/heparin nanoparticles for stomach-specific anti-Helicobacter pylori therapy

(2009) Yu-Hsin Lin et al.   BIOMATERIALS

The Roles of Antimicrobial Peptides in Innate Host Defense

(2009) Gill Diamond et al.   CURRENT PHARMACEUTICAL DESIGN

Loss of mannosylphosphate from Candida albicans cell wall proteins results in enhanced resistance to the inhibitory effect of a cationic antimicrobial peptide via reduced peptide binding to the cell surface

(2009) Mark Harris et al.   MICROBIOLOGY-SGM

Structure, membrane orientation, mechanism, and function of pexiganan — A highly potent antimicrobial peptide designed from magainin

(2008) Lindsey M. Gottler et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Antibacterial and Hemolytic Activities of Quaternary Pyridinium Functionalized Polynorbornenes

(2008) Tarik Eren et al.   MACROMOLECULAR CHEMISTRY AND PHYSICS

Unknown

(2008) Lars Steinstraesser et al.   MOLECULAR MEDICINE